Radiation Therapy

If you have been NEWLY DIAGNOSED  START HERE 

Cancer Journey


VIDEOS

Radiation therapy can be very helpful in treating painful bone metastases or those at risk for causing a fracture due to compromise of bone strength...

Radiation Oncologist Dr. Vivek Mehta reviews the concept of using whole brain radiation for multiple brain metastases, including how it is delivered...

ARTICLES

When I met my first lung cancer patient in medical school, I found it difficult to grasp the wording of the diagnosis non-small cell lung cancer (and...

We've recently received a series of questions on the question of whether it makes sense to give an oral EGFR inhibitor like Tarceva (erlotinib) or...

One of the most common questions. we receive is why people are told that surgery isn't an appropriate option for metastatic disease. If you can see...

When I was a medical student, the question about lung cancer that was always asked on "the Boards" had to do with the difference between stage IIIA...

Here is the third and final case I discussed with two great experts in locally advanced NSCLC. Drs. George Blumenschein, medical oncologist from MD...

COMMUNITY FORUM

RECENT POSTS

RTOG 0617: Stunningly Worse Survival for High Dose Radiation in Locally Advanced NSCLC, but Carbo-Taxol Has Never Looked Better

Article

The Radiation Therapy Oncology Group (RTOG) has been working on a large randomized trial in patients with stage III, locally advanced, unresectable NSCLC that asked two key questions:

1) is the best dose of radiation the "old" standard of 60 Gray (Gy), over about 6 weeks, or a higher dose of 74 Gy that has been found to be feasible?

2) Is there a value in adding weekly Erbitux (cetuximab), the antibody to the epidermal growth factor receptor (EGFR), along with weekly carboplatin/Taxol (paclitaxel) and concurrent chest radiation therapy (RT)?

When might local therapy be a good choice for someone with metastatic lung cancer?

Article

I've mentioned in posts in the past about the settings in which local therapy might be appropriate for someone even when we know the cancer is advanced/metastatic.  Here's a brief video that discusses some of these issues, including a situation in which the local treatment isn't specifically aimed at addressing a symptom, as is the usual reason for treating with local therapy for metastatic cancer, but is rather what I'd consider the "Get the Lead Runner" strategy:

[powerpress]

I'm interested in your thoughts.

Less is More: High Dose Radiation Not Better When Given Concurrent with Chemo for Locally Advanced NSCLC

Article

lucy_football Like Charlie Brown always thinking that this time will be different when he tries to kick the football without Lucy pulling it away, we get lulled into thinking that we know the intuitive, obvious answer in medicine without really testing it, only to find that our assumption was wrong yet again.

Brain Metastases in Lung Cancer: Still Room to Personalize Care

Article

For non-small cell lung cancer patients with multiple brain metastases, the standard approach of whole brain radiotherapy is not necessarily standard for each and every patient. Each patient's specific situation may sometimes be best approached with various combinations of surgery, radiation, medical/systemic therapy, and non-cancer directed treatment.

Adding EGFR Inhibitor Therapy to Radiation or Chemo/Radiation for Locally Advanced NSCLC

Article

We've recently received a series of questions on the question of whether it makes sense to give an oral EGFR inhibitor like Tarceva (erlotinib) or Iressa (gefitinib) concurrently with radiation. This is really a poorly studied question, but a paper just published in the Journal of Thoracic Oncology describes a clinical trial that helps to address this question.

Subscribe to Radiation Therapy